(Press-News.org) (Wednesday, 25 September 2024, Amsterdam, Netherlands) A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.1
This is the first study to explore the use of semaglutide for HS, marking a critical milestone in the search for effective treatments for this painful and debilitating condition.
HS is currently estimated to affect approximately 1 in 100 people, with obesity being a significant risk factor. The condition is characterised by painful abscesses and scarring, which can severely impact patients’ quality of life.2 Despite advancements in managing HS, effective treatments remain limited and can cause serious side effects, highlighting a need for alternative and better-tolerated treatment options.3
The study, which examined data from June 2020 to March 2023, assessed health outcomes for 30 obese patients (27 females, 3 males, average age 42) with varying stages of HS. Patients received semaglutide – a glucagon-like peptide (GLP)-1RA – at a once-weekly mean dose of 0.8mg for an average of 8.2 months.
Researchers monitored changes in body mass index (BMI), weight, flare frequency, Dermatology Life Quality Index (DLQI) value*, and pain levels before and after starting semaglutide, as well as biochemical markers, including C-reactive protein (CRP), glucose and haemoglobin A1c (HbA1c) levels.
The results showed marked improvements in patient outcomes across several key measures.
Patients experienced fewer HS flare-ups, with the frequency of these episodes reducing from an average of once every 8.5 weeks to once every 12 weeks. Quality of life also improved significantly, reflected in a reduction of the DLQI score from an average of 13/30 to 9/30. Notably, one-third of patients achieved a DLQI score reduction of four points or more, equalling or surpassing the minimally important differences for this index.
The average BMI of patients decreased from 43.1 to 41.5 and their mean weight dropped significantly from 117.7kg to 111.6kg, with one-third of patients losing 10kg or more during the treatment period.
Further positive changes were observed in the biochemical markers assessed. HbA1c levels decreased from 39.3 to 36.6, indicating better glycaemic control, while average CRP levels fell from 7.8 to 6.9, signifying reduced inflammation.
Dr Daniel Lyons, lead researcher from St Vincent’s University Hospital, Dublin, Ireland, explains, “Our findings suggest that semaglutide, even at modest doses, can offer substantial benefits in managing HS. While the drug’s role in promoting weight loss is well-established, what’s particularly exciting is its potential to also reduce the frequency of HS flare-ups, contributing to the notable improvements observed in patients’ quality of life.”
Dr Lyons adds, “The results are highly encouraging and could represent a major breakthrough in HS treatment. To build on this progress, larger randomised controlled trials are necessary to validate these findings. Additionally, future research should explore the impact of higher doses of semaglutide and its effects independently of concomitant medications to fully understand its potential.”
He concludes, “Ultimately, we hope our preliminary data will encourage dermatologists to consider weight loss medication as an adjunct to existing HS treatments and inspire further research in this area aimed at improving outcomes for people living with this challenging condition.”
END
Note to editors:
A reference to the EADV Congress 2024 must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact press@eadv.org.
Key terms defined:
Dermatology Life Quality Index (DLQI): a self-administered validated questionnaire designed to measure the health-related quality of life of adults suffering from a skin disease. The DLQI value is calculated by adding the score of each question, resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired. A score higher than 10 indicates that the patient’s life is being severely affected by their skin disease.4
About the study author:
Dr. Daniel Lyons is part of the Department of Dermatology at St Vincent’s University Hospital, Dublin, Ireland.
About EADV:
Founded in 1987, EADV is a non-profit organisation with a vision to form a premier European Dermatology-Venereology Society. The Academy counts over 11,000 members from all around the globe, providing a valuable service for every type of dermatologist-venereologist professional. The EADV is dedicated to advancing patient care, education and research by providing a unique platform to bring people together and share ideas.
This year, the EADV Congress will take place in Amsterdam, The Netherlands, and online from 25-28 September 2024. Find out more: https://eadv.org/congress/
References:
Lyons, D., Nathan, A., Pender, E., Murray, G., Smith, C., Kirby, B., & Hughes, R. (2024). Semaglutide for weight loss in obese patients as an adjunctive treatment for hidradenitis suppurative: Its impact on disease control and quality of life. Presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024.
NHS. (2023). Hidradenitis suppurativa (HS). Retrieved from https://www.nhs.uk/conditions/hidradenitis-suppurativa/#:~:text=The%20exact%20cause%20of%20hidradenitis,about%201%20in%20100%20people
The Health Policy Partnership. (2024). Call to action: improving the lives of people with hidradenitis suppurative (HS) in the United Kingdom. Retrieved from: https://www.nhs.uk/conditions/hidradenitis-suppurativa/#:~:text=The%20exact%20cause%20of%20hidradenitis,about%201%20in%20100%20people
Cardiff University. (2019). Dermatology Life Quality Index. Retrieved from: https://www.cardiff.ac.uk/medicine/resources/quality-of-life-questionnaires/dermatology-life-quality-index END
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes.
With this novel treatment proving to be very effective, researchers are curious to know more about what other potential treatments it could also hold.
Researchers at the University of Michigan investigated another potential way GLP1RA drugs can be useful in treating type two diabetes associated with a genetic condition that causes high levels of iron, called hereditary hemochromatosis.
High iron levels with hereditary hemochromatosis can cause predisposition to liver disease ...
TUCSON, Ariz., Sept. 19, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) focused Broad Agency Announcement (BAA) contract from the U.S. Food and Drug Administration (FDA). The overarching objective of the work supported by the BAA award is to leverage collaboration with the Wake Forest Rare Inherited Kidney Disease team and its ADTKD registry, to analyze clinical and laboratory data that will help evaluate prognosis in ADTKD and help set the stage for future clinical trials.
ADTKD only affects ...
Hot carrier solar cells, a concept introduced several decades ago, have long been seen as a potential breakthrough in solar energy technology. These cells could surpass the Shockley–Queisser efficiency limit, which is a theoretical maximum efficiency for single-junction solar cells. Despite their promise, practical implementation has faced significant challenges, particularly in managing the rapid extraction of hot electrons across material interfaces.
Recent research has focused on using satellite valleys in the conduction band to temporarily store hot electrons before collection. However, ...
(MEMPHIS, Tenn. – Sept. 24, 2024) – Clinical trial results from St. Jude Children’s Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL). Traditionally, the intensity of a patient’s chemotherapy regime is guided by the National Cancer Institute (NCI) risk classification, which is largely determined by clinical characteristics such as age and white blood cell count at presentation. Through the flagship St. Jude ...
Researchers at the Beckman Institute for Advanced Science and Technology demonstrated that emotion enhances memory for contextual details, challenging the view that emotion impairs the ability to remember such information.
The report was led by doctoral student Paul Bogdan, currently a postdoc at Duke University, and Florin and Sanda Dolcos, professors of psychology and neuroscience at the University of Illinois Urbana-Champaign.
Their research appears in the Journal of Experimental Psychology: ...
In a review of previous studies, a Johns Hopkins Children’s Center team concludes that some video games created as mental health interventions can be helpful – if modest – tools in improving the mental well-being of children and teens with anxiety, depression and attention-deficit/hyperactivity disorder (ADHD).
A report on the review of studies from peer-reviewed journals between 2011 and March 20, 2024, was published Sept. 23, 2024, in JAMA Pediatrics.
An estimated 20% of children and teenagers between the ages of three and 17 in the U.S. have a mental, emotional, developmental or behavioral ...
Following Barack Obama’s reelection as U.S. president in 2012, the mental health of college-educated Black men improved significantly, while those who didn’t attend college reported worse mental health, according to new research from Rice University sociologists.
“Four More Years! Or So What? The Mental Health Significance of Barack Obama’s 2012 Presidential Re-Election among Black Adults” will appear in an upcoming edition of Du Bois Review: Social Science Research on Race.
Lead researcher Tony Brown, distinguished professor of sociology at Rice, said he and his co-authors were interested in following up ...
Toronto -- Modern crowdfunding has grown from relatively modest beginnings in the late 1990s to a multi-billion-dollar financing market for all kinds of early-stage innovations. The platform Kickstarter alone went from $276 million pledged in 2012 to $7.8 billion in 2024. There are even professional project designers to help craft that winning proposal.
With stakes like those, getting the pitch right is everything.
Enter machine learning to assist. Researchers from the University of Toronto’s Rotman School of Management put four different types of this artificial intelligence application to the test, including Deep Learning. Machine learning proved not only superior ...
Pharmacists now have more guidance in combatting the opioid crisis and providing treatment to patients thanks to new national guidelines developed at the University of Houston College of Pharmacy. The Pharmacy Access to Resources and Medication for Opioid Use Disorder Guideline, released today, addresses critical barriers in the treatment of Opioid Use Disorder across the nation’s community pharmacies.
With approximately 2.7 million individuals in the U.S. affected by OUD, the need for effective management strategies has never been more urgent. The PhARM-OUD Guideline marks a significant advancement as ...
A new analysis of satellite data finds that the record surge in atmospheric methane emissions from 2020 to 2022 was driven by increased inundation and water storage in wetlands, combined with a slight decrease in atmospheric hydroxide (OH). The results have implications for efforts to decrease atmospheric methane and mitigate its impact on climate change.
“From 2010 to 2019, we saw regular increases – with slight accelerations – in atmospheric methane concentrations, but the increases that occurred from ...
